Stereotactic body radiation therapy for early-stage non-small cell lung cancer in the USA: patterns of adoption and potential healthcare disparities
- 2 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Radiation Oncology
- Vol. 9 (3-4), 225-234
- https://doi.org/10.1007/s13566-020-00442-y
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR001855, UL1TR000130)
This publication has 22 references indexed in Scilit:
- Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based AnalysisJournal of Thoracic Oncology, 2015
- Cancer survival disparities by health insurance statusCancer Medicine, 2013
- Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?International Journal of Radiation Oncology*Biology*Physics, 2011
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II StudyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry StudiesPLoS Medicine, 2008
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Extracranial Stereotactic Radioablation *Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003
- Racial Differences in the Treatment of Early-Stage Lung CancerThe New England Journal of Medicine, 1999
- Social factors, treatment, and survival in early-stage non-small cell lung cancer.American Journal of Public Health, 1998